What You Might Not Know About Your Breast Cancer Risk→

/
What You Might Not Know About Your Breast Cancer Risk

Rochelle highlights that breast cancer risk is not the same for every woman, and understanding your personal risk profile is key to early detection and prevention.

While general statistics offer a broad picture, individual risk is shaped by factors such as family history, genetics, lifestyle and overall health.

She encourages open conversations with healthcare professionals and proactive assessment from an early age, as knowing your risk can lead to more tailored screening, informed choices and greater control over your health.

Read More

Team‑Based Care Makes All the Difference in Multiple Myeloma→

/
Team‑Based Care Makes All the Difference in Multiple Myeloma

The second most-common blood cancer, multiple myeloma is a cancer of plasma cells — part of the immune system — and it often behaves differently from many other cancers. Instead of following a single treatment path, multiple myeloma tends to change over time. Treatments may stop working and need adjustment, and patients often move through periods of remission and relapse — requiring ongoing decisions about when to start treatment, how aggressive it should be and how to manage side effects.

Read More

Sylvester Comprehensive Cancer Center’s Dr. Jashodeep Datta Wins Stanley J. Glaser Award for Pancreatic Cancer Immunotherapy→

/
Sylvester Comprehensive Cancer Center’s Dr. Jashodeep Datta Wins Stanley J. Glaser Award for Pancreatic Cancer Immunotherapy

At Sylvester Comprehensive Cancer Center, part of University of Miami Miller School of Medicine, innovation begins with a question, the kind that sits just beyond what science currently understands. For Jashodeep Datta, M.D., the DiMare Family Endowed Chair in Immunotherapy and associate professor in the Division of Surgical Oncology at the Miller School, those questions have driven a career defined by curiosity, rigor and a deep commitment to improving outcomes for patients with some of the most lethal cancers.

Read More

Why Collaborative Care Is Changing What It Means to Live With Multiple Myeloma→

/
Why Collaborative Care Is Changing What It Means to Live With Multiple Myeloma

Multiple myeloma is the second most-common blood cancer, and it rarely follows a straight path. It evolves over time, responds differently to treatment in each patient and often requires a mix of therapies, including immunotherapies, antibodies, targeted drugs, chemotherapy, CAR T-cell therapy and bone marrow or stem cell transplants.

Read More

Colon Cancer Is Rising in Younger Adults — Use This Prevention Checklist to Reduce Your Risk →

/
Colon Cancer Is Rising in Younger Adults — Use This Prevention Checklist to Reduce Your Risk

Colorectal cancer is increasingly being diagnosed in younger people, including those in their 20s, 30s and 40s, often with few or no early warning signs. This shift has reshaped how physicians think about prevention. It has prompted national experts to lower the recommended age to begin screening to 45 for individuals at average risk.

Read More

Sylvester Comprehensive Cancer Center Researcher Wins Stanley J. Glaser Award for Colorectal Cancer Immunotherapy→

/
Sylvester Comprehensive Cancer Center Researcher Wins Stanley J. Glaser Award for Colorectal Cancer Immunotherapy

In science, progress rarely moves in a straight line. It advances more like a river—branching, looping back on itself, sometimes disappearing underground before resurfacing with new force. For Kevin Van der Jeught, Ph.D., that winding path has led to a moment of recognition. He received a Stanley J. Glaser Foundation Award, honoring his innovative work in colorectal cancer and immunotherapy.

Read More

Scratching for an Explanation for Psoriatic Itchy Scalp

/
Scratching for an Explanation for Psoriatic Itchy Scalp

Psoriatic scalp itch may have a larger neural component than previously thought, with neuroimmune mediators — rather than the histamine system — controlling the severity of this type of itch, according to a study led by Miller School of Medicine researchers.

Read More